Year: 2025
Type: article
Abstract: Amino Acid Sequence: The MEQ Enzyme Inhibitor is designed to target and inhibit specific enzymes involved in neurological disorders, such as acetylcholinesterase or monoamine oxidase. The inhibitor's sequence includes regions that bind with high affinity to the enzyme's active site, blocking its activity and altering disease progression. Modifications: The enzyme inhibitor may include modifications such as PEGylation to enhance stability and prolong its half-life in the bloodstream. Other modifications can be made to increase specificity and reduce potential off-target effects, ensuring precise inhibition of the target enzyme.
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4413237367